We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Albemarle (ALB) Exceeds Market Returns: Some Facts to Consider
Read MoreHide Full Article
Albemarle (ALB - Free Report) closed the latest trading day at $128.87, indicating a +1.89% change from the previous session's end. The stock's performance was ahead of the S&P 500's daily gain of 0.11%. Meanwhile, the Dow lost 0.11%, and the Nasdaq, a tech-heavy index, added 0.23%.
The the stock of specialty chemicals company has risen by 15.61% in the past month, leading the Basic Materials sector's gain of 6.66% and the S&P 500's gain of 1.5%.
Market participants will be closely following the financial results of Albemarle in its upcoming release. On that day, Albemarle is projected to report earnings of $0.53 per share, which would represent a year-over-year decline of 94.86%. At the same time, our most recent consensus estimate is projecting a revenue of $1.45 billion, reflecting a 43.86% fall from the equivalent quarter last year.
For the full year, the Zacks Consensus Estimates project earnings of $3.15 per share and a revenue of $5.72 billion, demonstrating changes of -85.84% and -40.53%, respectively, from the preceding year.
Investors should also note any recent changes to analyst estimates for Albemarle. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 2.9% downward. As of now, Albemarle holds a Zacks Rank of #4 (Sell).
In terms of valuation, Albemarle is currently trading at a Forward P/E ratio of 40.15. This indicates a premium in contrast to its industry's Forward P/E of 18.69.
One should further note that ALB currently holds a PEG ratio of 2.51. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. As the market closed yesterday, the Chemical - Diversified industry was having an average PEG ratio of 1.18.
The Chemical - Diversified industry is part of the Basic Materials sector. At present, this industry carries a Zacks Industry Rank of 181, placing it within the bottom 29% of over 250 industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Albemarle (ALB) Exceeds Market Returns: Some Facts to Consider
Albemarle (ALB - Free Report) closed the latest trading day at $128.87, indicating a +1.89% change from the previous session's end. The stock's performance was ahead of the S&P 500's daily gain of 0.11%. Meanwhile, the Dow lost 0.11%, and the Nasdaq, a tech-heavy index, added 0.23%.
The the stock of specialty chemicals company has risen by 15.61% in the past month, leading the Basic Materials sector's gain of 6.66% and the S&P 500's gain of 1.5%.
Market participants will be closely following the financial results of Albemarle in its upcoming release. On that day, Albemarle is projected to report earnings of $0.53 per share, which would represent a year-over-year decline of 94.86%. At the same time, our most recent consensus estimate is projecting a revenue of $1.45 billion, reflecting a 43.86% fall from the equivalent quarter last year.
For the full year, the Zacks Consensus Estimates project earnings of $3.15 per share and a revenue of $5.72 billion, demonstrating changes of -85.84% and -40.53%, respectively, from the preceding year.
Investors should also note any recent changes to analyst estimates for Albemarle. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 2.9% downward. As of now, Albemarle holds a Zacks Rank of #4 (Sell).
In terms of valuation, Albemarle is currently trading at a Forward P/E ratio of 40.15. This indicates a premium in contrast to its industry's Forward P/E of 18.69.
One should further note that ALB currently holds a PEG ratio of 2.51. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. As the market closed yesterday, the Chemical - Diversified industry was having an average PEG ratio of 1.18.
The Chemical - Diversified industry is part of the Basic Materials sector. At present, this industry carries a Zacks Industry Rank of 181, placing it within the bottom 29% of over 250 industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.